Adroitest Panacea Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2018
- Revenue Growth %
- Profit Growth -11.90%
- Net Worth -61.26%
- Total Assets 0.52%
About Adroitest Panacea
Adroitest Panacea Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 November 2012 and has a history of 12 years and two months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vinay Ambardekar and Yogesh Jangir serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74120MH2012PTC238403
-
Company No.
238403
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Nov 2012
-
Date of AGM
18 Sep 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Adroitest Panacea?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Ambardekar
|
Director | 24-Aug-2020 | Current |
|
Yogesh Jangir
|
Additional Director | 13-May-2021 | Current |
Financial Performance of Adroitest Panacea.
Adroitest Panacea Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 11.9% decrease in profit. The company's net worth observed a substantial decline by a decrease of 61.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adroitest Panacea?
In 2018, Adroitest Panacea had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Spheero Developers LimitedYogesh Jangir is a mutual person
-
Ticket Utils India Private LimitedVinay Ambardekar is a mutual person
-
Macvin Consultancy Private LimitedVinay Ambardekar is a mutual person
-
Parthenon India Private LimitedVinay Ambardekar is a mutual person
-
Kmc Infratech LimitedVinay Ambardekar is a mutual person
-
Rajesh Signaturespaces Private Limited
Vinay Ambardekar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adroitest Panacea?
Adroitest Panacea has a workforce of 17 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adroitest Panacea, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adroitest Panacea's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
